PBS293-MMAE targets EGFR and EphA2, two proteins shown to be co-expressed in colorectal cancer cells. While EGFR is a clinically validated target in colorectal cancer, therapeutic antibodies such as ...

Promatix Biosciences Ltd (Promatix), an emerging UK-based biotechnology company developing innovative new classes of cancer therapies using cis-bispecific antibodies, today presented positive ...

HER2-positive gastric cancer accounts for a substantial proportion of advanced cases and has long been treated with HER2-targeted therapies. While trastuzumab deruxtecan has shown superior activity ...

From billion-dollar licensing deals to advances in cancer therapies and artificial intelligence, Chinese biotech firms are ...

Over the past years, I have closely followed the evolution of the global oncology industry. What I have observed is steady, ...

Discover six RNAi biotech companies helping to drive momentum in a field that can precisely target disease at its genetic root.

As the electric vehicle era enters full scale, demand is increasing for batteries that can travel farther and last longer. Lithium-metal batteries ...

Can you describe how the untargeted ultrahigh-performance liquid chromatography–high resolution tandem mass spectrometry (UHPLC–HRMS/MS) workflow was designed to capture both known salicylates and ...

To My Shabbat Soul, I owe you an apology. For years you stood at the corner of my week, softly waving, while I sprinted past ...

As demands for aseptic manufacturing increase, partnerships with solutions providers will be key to ensuring safe, versatile and optimized drug containment.

Many homes across Ghana often blame pneumonia on cold weather, rain, sleeping on bare floors, bathing at night, or sleeping ...

Detailed price information for Adc Therapeutics Sa (ADCT-N) from The Globe and Mail including charting and trades.